Search
Selected Filter
Displaying 11–20 of 185 research results
-
AGTC Reports Promising Interim Results for XLRP and Achromatopsia Gene Therapy Trials
AGTC used Foundation’s My Retina Tracker registry to recruit patients for trials
-
Consortium Genetically Tests 40 Percent of People in Israel with IRDs
Patient benefits from genetic testing for IRDs include confirmation of their clinical diagnosis, identification of the disease inheritance pattern and risk for other family members, and determination of human studies for emerging therapies that may be appropriate for them.
-
The treatment focuses on the P23H mutation in the RHO gene, which is the most prevalent variant causing adRP in the US and affects approximately 2,500 people.
-
Allergan and Editas Begin Recruiting for CRISPR/Cas9 Clinical Trial for LCA10
The trial will be the first for a CRISPR/Cas9 therapy administered inside the human body.
-
The Foundation’s Contributions to Genetic Research Published in Peer-Reviewed Journal
The nonprofit has emerged as a driving force in genetic research and treatment development for inherited retinal diseases.
-
SparingVision Gets EU Funding Boost for Development of Cross-Cutting Gene Therapy
A clinical trial for the treatment, designed to preserve cone photoreceptors, is planned in the US and Europe in 2020.
-
The Retina is a Proving Ground for a Broad Range of Neurological Therapies
Retinal research paves the way for new treatments for the entire neurological system.
-
FDA Wins Case against Stem-Cell Clinic that Blinded Patients with Bogus Treatment
A federal court ruled that the FDA has regulatory authority over these stem-cell procedures and the power to halt them.
-
Stargardt Disease Research Advances
Recent developments in research on Stargardt disease
-
Dr. Don Zack Honored for Research Contributions by ARVO and the Foundation Fighting Blindness
Dr. Zack is a member of the Foundation’s Scientific Advisory Board and chairs its Cellular Molecular Mechanisms of Disease study section.
